Skip to main content

The Strategy of Treatment of Hodgkin’s Disease

  • Chapter
Tactics and Strategy in Cancer Treatment

Abstract

The treatment of Hodgkin’s disease has greatly evolved during the last decade. It has actually reached a degree of maturity which can lead to a general consensus on the main points [1, 6, 7, 8, 9].

Communication to the 1976 Villejuif-Paris Immuno-Oncology Week.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Chauvergne, J., Hcerni, B., Hœrni-Simon, G., Durand, M., Lagarde, C.: Chimiothérapie de la maladie de Hodgkin associant procarbazine, vinblastine, cyclophosphamide et methyl-prednisolone. Analyse d’une série de 124 cures. Z. Krebsforsch, 80, 179–188 (1973).

    Article  CAS  Google Scholar 

  2. De Vita, V. T., Serpick, A. A., Carbone, P. P.: Combination chemotherapy in the treatment of advanced Hodgkin’s disease. Ann. intern. Med. 73, 881–895 (1970).

    Google Scholar 

  3. E.O.R.T.C. Radiochemotherapy Group: Splenectomy vs splenic irradiation. Annual plenary meeting of the E.O.R.T.C., June 24, 1976

    Google Scholar 

  4. Hœrni, B., Chauvergne, J., Hœrni-Simon, G., Durand, M., Lagarde, C.: The utility of BCG in the immunotherapy of malignant lymphomas. Results of a controlled trial. Cancer Immunol. Immunother. (1977) (in press).

    Google Scholar 

  5. Hœrni, B., Chauvergne, J., Touchard, J., Meugé, C., Hœrni-Simon, G., Durand, M., Brunet, R., Lagarde, C.: Résultats du traitement de la maladie de Hodgkin. Stades cliniques I et II, Fondation Bergonié, 1965–1975. Ilème Congrès français d’Hématologie, Le Touquet, 25 mai 1976.

    Google Scholar 

  6. Lagarde, C., Chauvergne, J., Hœrni, B.: La maladie de Hodgkin. Paris: Masson et Cie, 1971.

    Google Scholar 

  7. Lagarde, C., Chauvergne, J., Hœrni, B.: Les lymphomes malins. Paris: Masson, 1975.

    Google Scholar 

  8. Lagarde, C., Chauvergne, J., Touchard, J., Durand, M., Hœrni-Simon, G., Brunet, R.: Traitement des stades cliniques I et II de maladie de Hodgkin. Résultats obtenus chez 100 malades par l’association à la radiothérapie d’un ou deux cycles de chimiothérapie. Acta Haemat. 55, 257–264 (1976).

    Article  PubMed  CAS  Google Scholar 

  9. Mathé, G., Tubiana, M.: The natural history, diagnosis and treatment of Hodgkin’s disease. Series hasmat. 6, 5–269 (1973).

    Google Scholar 

  10. Rosenberg, S. A., Kaplan, H. S.: The manage6ment of stages I, II and III of Hodgkin’s disease with combined radiotherapy and chemotherapy. Cancer, Philad. 35, 55–63 (1975).

    Article  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1977 Springer-Verlag Berlin · Heidelberg

About this chapter

Cite this chapter

Hœrni, B., Chauvergne, J., Lagarde, C. (1977). The Strategy of Treatment of Hodgkin’s Disease. In: Mathé, G. (eds) Tactics and Strategy in Cancer Treatment. Recent Results in Cancer Research / Fortschritte der Krebsforschung / Progrès dans les recherches sur le cancer, vol 62. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-81174-6_16

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-81174-6_16

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-81176-0

  • Online ISBN: 978-3-642-81174-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics